World of DTC Marketing
DECEMBER 1, 2020
Just look at any pharma product website that is nothing but a sales brochure in a majority of cases. ROI drives pharma companies. In the past, pharma product websites had a huge effect on whether a patient asks for an Rx. 5ive: It’s time to update clinical trial information. Want proof? 3d render ).
World of DTC Marketing
OCTOBER 29, 2020
When online health seekers come to a pharma product website they want to know “what’s in it for me?” ” and “how much the drug costs” Sure, they will go to the product safety information page but it’s too hard for them to comprehend. It’s a huge waste of space, money, and time.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
MARCH 1, 2023
In the last few years, there have been growing calls to onshore the manufacturing of certain pharma products, including active pharmaceutical ingredients (API), to ensure a smooth supply and to minimise shortages in the European Union (EU). All this, and the latest pharma industry news, comment, and analysis from GlobalData.
Pharmaceutical Technology
AUGUST 30, 2022
Brazilian pharma production sites are involved in Covid-19 vaccine and therapy manufacture. Oswaldo Cruz Foundation will package the drug in its facility in Rio de Janeiro before supplying it to the Brazilian public health system; the company is also involved in clinical trials for the drug’s possible use as Covid-19 prophylaxis.
World of DTC Marketing
FEBRUARY 9, 2021
In clinical trials, how many people experienced a listed side effect? In the top pharma product websites that we showed groups, they really disliked the website’s overall appearance and described it as “cold and unappealing.” First impressions are 94% design-related. 6ix: Safety information needs context.
pharmaphorum
FEBRUARY 18, 2022
The optimistic assessment of the revenue potential for androgen receptor inhibitor Nubeqa (darolutamide) follows the publication of the results of the phase 3 ARASENS trial in the New England Journal of Medicine. compared to standard therapy alone.
Pharmaceutical Technology
JULY 4, 2022
Pfizer (New York, New York) has announced that it will not begin any new clinical trials in Russia and will halt recruitment in trials that are underway in Russia. In addition, our clinical trial service delivery in Ukraine has been temporarily halted and will resume once safe to do so.”.
Expert insights. Personalized for you.
186 
Let's personalize your content